Elsevier Inc.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Paik
    Paik
  3. Travis
    Travis
  4. Rekhtman
    Rekhtman
  5. Riely
    Riely
  6. Rusch
    Rusch
  7. Zauderer
    Zauderer
  8. Arcila
    Arcila
  9. Chaft
    Chaft
  10. Drilon
    Drilon

Groups

  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (12)
  3. Thoracic Oncology (12)
  4. Surgery (4)
  5. GSK Faculty (3)
  6. Radiology, Department of (3)
  7. Body Imaging Service (2)
  8. Human Oncology and Pathogenesis Program (2)
  9. Population Sciences Research Program (2)
  10. Survivorship Research (2)
Search Within
  1. "Meeting abstract"
  2. "Camelia Sima"
  3. "Mark Kris"
Formats
  1. Meeting Abstract (12)
Groups
  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (12)
  3. Thoracic Oncology (12)
  4. Surgery (4)
  5. GSK Faculty (3)
  6. Radiology, Department of (3)

More Groups

People
  1. Camelia Sima (12)
  2. Mark Kris (12)
  3. Matthew Hellmann (4)
  4. Paul Paik (4)
  5. William Travis (4)
  6. Gregory Riely (3)

More People

Years
  1. 2015 (4)
  2. 2013 (6)
  3. 2011 (2)
Publications
  1. Journal of Thoracic Oncology (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic molecular testing in multiple lung cancers
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M. E.; Finley, D. J.; Rusch, V.; Jones, D. R.; Kris, M. G.; Zauderer, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of patients with metastatic KRAS mutant lung cancers
    Meeting Abstract

    Riely, G.; Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K-aberrant and FGFR1 amplified stage IV squamous cell lung cancers (SQCLCs)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Rekhtman, N.; Sima, C. S.; Won, H.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)
    Meeting Abstract

    Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save